Clinical Trials for Chronic Phase Chronic Myelogenous Leukemia

Find clinical trials for chronic phase chronic myelogenous leukemia. Discover research opportunities and treatment options in your area.

3 Active Trials Found

Showing 3 trials on this page

Page 1 of 1

Protocol Number: HJKC3-0003. Treatment Free Remission After Combination Therapy With Asciminib (ABL001) Plus Tyrosine Kinase Inhibitors (TKI) in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation

NCT ID: NCT04838041

This clinical trial is studying a treatment approach for patients with chronic phase chronic myeloid leukemia (CML) who have previously tried to stop taking certain medications known as Tyrosine Ki...

Recruiting

Phase: PHASE2 Type: interventional Locations: Salt Lake City, Utah, United States, New York, New York, United States +2 more

ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic Phase

NCT ID: NCT05007873

This clinical trial is exploring the use of two medications, ASTX727 and dasatinib, to treat patients who have recently been diagnosed with a type of blood cancer called chronic myeloid leukemia (C...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts W/Chronic Myeloid Leukemia

NCT ID: NCT06229860

This clinical trial is looking at how a person’s personality might affect their ability to stick to treatment with specific cancer medications called tyrosine kinase inhibitors in patients with chr...

Recruiting

Type: observational Locations: Orange, California, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions